Catalysts for Balversa
11 tracked
Oct 17, 2025
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Oct 9, 2024
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Jan 19, 2024
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Jan 19, 2024
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Jan 19, 2024
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Mar 20, 2023
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Jan 11, 2023
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Apr 27, 2022
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Apr 27, 2022
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Apr 2, 2020
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Apr 12, 2019
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→